Abstract: The invention describes novel steroidal compounds, compositions containing the same, and methods of using the same as SREBP inhibitors, as LXR agonists, or as dual modulators of SREBP and LXR, to treat SREBP and/or LXR mediated diseases.
Type:
Grant
Filed:
April 22, 2023
Date of Patent:
October 28, 2025
Assignee:
Asteroid Therapeutics
Inventors:
Antonio Feula, Francesco G Salituro, Ryan Edward Stites